Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation.

Source:http://linkedlifedata.com/resource/pubmed/id/19123003

Download in:

View as

General Info

PMID
19123003